We are delighted to announce that Dr Caroline Brammer has been appointed Interim Medical Director of The Clatterbridge Cancer Centre NHS Foundation Trust with effect from Monday 4th August 2025 following a formal recruitment process.
Caroline is currently our Associate Medical Director for Radiation Services. She is also a practising Consultant Clinical Oncologist specialising in head and neck cancer with clinics at our Aintree, Liverpool and Wirral sites.
Caroline joined the Trust in 2013 and played a key role in helping to shape plans and the clinical model for the new Clatterbridge Cancer Centre – Liverpool, which opened in June 2020.
She studied in Sheffield and completed her specialist training in the East Midlands and Yorkshire, as well as spending a year in New Zealand as an oncology registrar.
It was during her final year as a medical student in Sheffield that she really became interested in oncology, thanks to a seminar about early research into the possibility identifying cancer genes and developing treatments that would target them.
Caroline had been a Consultant Clinical Oncologist in Wolverhampton for 14 years before joining The Clatterbridge Cancer Centre in 2013, initially as Clinical Director for Integrated Care. Her achievements here include establishing our Clinical Decisions Unit providing urgent assessment and emergency cancer care in 2018.
She will succeed our current Medical Director Dr Sheena Khanduri, who is leaving the Trust at the end of July to become Chief Medical Officer of a specialist oncology company.
Chief Executive Joan Spencer said:
Caroline is a superb clinician and a skilled and effective clinical leader who is committed to excellent patient care. I am really delighted to be welcoming her to the executive team as our new Medical Director and look forward to working with her in her new role.
Dr Caroline Brammer said:
The Clatterbridge Cancer Centre is a strong performer delivering really high-quality tertiary cancer care and we want to maintain that. At the same time, there is more we can do with our health and social care partners to look at the whole cancer pathway and the care people receive pre-diagnosis. I am excited to be taking on this role and continuing Sheena’s great work.
